At present the phenotype of transgenic models of disorders of the nervous systems (e.g., SHANK3 deletion syndrome or PMS) are descriptive, based on observation, interpretation of the observed behaviors and at best using computerized assessments from hand coded descriptions that are then built into the heuristics of a computer program. This evidence concerns the gene SHANK3 and nervous system disorder.